Description
Sales of Human Immunodeficiency Virus (HIV) medications used to treat HIV/AIDS make up the HIV drug industry. Antiretroviral drug companies that manufacture antiretroviral drugs such as nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, entry and fusion inhibitors, integrase inhibitors, and protease inhibitors for the treatment of HIV infection generate revenue in this market.
The Global HIV Drug market size was valued at US$ 25.1 Billion in 2020 and projected to reach US$ 35.3 Billion by 2027, growing at a CAGR of 3.2% during the forecast period, 2021-2027. The rising prevalence of HIV and its diagnosis is one of the key factors driving the global HIV medications market forward. A surge in government efforts to raise public awareness about causes, symptoms, and treatments also impacts the market. Furthermore, the emergence of generic pharmaceuticals, which are less expensive and chemically identical to branded treatments, contributes to the demand for HIV medications.
